Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06036199 · ClinicalTrials.gov registry record · NA

Focused Ultrasound Pallidotomy for Dyskinetic Cerebral Palsy in Pediatric and Young Adult Subjects

A NA study of Cerebral Palsy, Dyskinetic and Secondary Dystonia, sponsored by Children's National Research Institute.

Recruiting
Registry status
NA
Development phase
10
Enrollment target
1
Study location

NCT06036199 is a NA study of Cerebral Palsy, Dyskinetic and Secondary Dystonia that is actively recruiting participants, run by Children's National Research Institute. The registered enrollment target is 10 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06036199, a NA study of Cerebral Palsy, Dyskinetic and Secondary Dystonia, is actively recruiting participants, sponsored by Children's National Research Institute.

RECRUITING
Registry status
NA
Development phase
10 participants
Enrollment target
1
Study location

Study Summary

The primary objective of the proposed study is to evaluate the safety of ExAblate Transcranial MRgFUS as a tool for creating bilateral or unilateral lesions in the globus pallidus (GPi) in patients with treatment-refractory secondary dystonia due to dyskinetic cerebral palsy

Interventions

  • DEVICE Focused Ultrasound Pallidotomy

Study Locations (1)

District of Columbia

  • Children's National Hospital - Washington D.C.

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2024-01-26
Est. Completion 2025-08
Phase NA

What the Registry Record Tells You About NCT06036199

The ClinicalTrials.gov registry entry for NCT06036199 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's National Research Institute, which has 92 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Cerebral Palsy, Dyskinetic appearing as the primary indexed condition, and to 1 intervention - of which Focused Ultrasound Pallidotomy is the first listed.

NCT06036199 reports 1 study location spanning 1 distinct geographic area - top geographies include District of Columbia.

Frequently Asked Questions

What is clinical trial NCT06036199 about?

NCT06036199 is a clinical study titled "Focused Ultrasound Pallidotomy for Dyskinetic Cerebral Palsy in Pediatric and Young Adult Subjects". The primary objective of the proposed study is to evaluate the safety of ExAblate Transcranial MRgFUS as a tool for creating bilateral or unilateral lesions in the globus pallidus (GPi) in patients with treatment-refractory secondary dystonia due to dyskinetic cerebral palsy

What is the current status of trial NCT06036199?

This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2024-01-26. Estimated completion is 2025-08.

What conditions does trial NCT06036199 study?

This clinical trial studies the following conditions: Cerebral Palsy, Dyskinetic, Secondary Dystonia.

What interventions are being tested in trial NCT06036199?

The interventions under investigation include: Focused Ultrasound Pallidotomy (DEVICE).

Who is sponsoring clinical trial NCT06036199?

This trial is sponsored by Children's National Research Institute, which has 92 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06036199 being conducted?

This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cerebral Palsy, Dyskinetic

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.